The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non‐replicating persistence
Open accessAbstract
Summary: Understanding the basis of bacterial persistence in latent infections is critical for eradication of tuberculosis. Analysis of Mycobacterium tuberculosis mRNA expression in an in vitro model of non‐replicating persistence indicated that the bacilli require electron transport chain components and ATP synthesis for survival. Additionally, low μM concentrations of aminoalkoxydiphenylmethane derivatives inhibited both the aerobic growth and survival of non‐replicating, persistent M. tuberculosis. Metabolic labelling studies and quantification of cellular menaquinone levels suggested that menaquinone synthesis, and consequently electron transport, is the target of the aminoalkoxydiphenylmethane derivatives. This hypothesis is strongly supported by the observations that treatment with these compounds inhibits oxygen consumption and that supplementation of growth medium with exogenous menaquinone rescued both growth and oxygen consumption of treated bacilli. In vitro assays indicate that the aminoalkoxydiphenylmethane derivatives specifically inhibit MenA, an enzyme involved in the synthesis of menaquinone. Thus, the results provide insight into the physiology of mycobacterial persistence and a basis for the development of novel drugs that enhance eradication of persistent bacilli and latent tuberculosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Multiple sequence alignment with hierarchical clustering.
Corpet, F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.22.10881 · Cited by 5,575
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 2×
“Because it has recently been shown that both the electron transport system and ATP synthesis are viable anti-TB drug targets (Andries et al., 2005; Weinstein et al., 2005) it was hypothesized that menaquinone synthesis could be critical for mycobacterial survival and the following studies were…”
BackgroundDistribution of isoprenoid quinone structural types in bacteria and their taxonomic implication
Collins, M. D., & Jones, D. A. (1981) · Microbiological Reviews · doi:10.1128/mr.45.2.316-354.1981 · Cited by 1,619
Escherichia coli and Salmonella.
Neidhart, F. C. (1996) · Cited by 1,577
Genetic requirements for mycobacterial survival during infection
Sassetti, C. M., & Rubin, E. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134250100 · Cited by 1,327
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G., Sherman, D. R., & Schoolnik, G. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030205 · Cited by 975
Research works printed but not linked: 3
- 10.1128/MMBR.45.2.316-354.1981 · DOI
- Meganathan R., 1996, Escherichia coli and Salmonella, 642
- Minnikin D.E., 1982, The Biology of Mycobacteria., 95
Cited by
Sorted by citations
Items 101–151 of 151
Alberti, M., Sainas, S., Ronchi, E., Lolli, M. L., Boschi, D., Rizzi, M., Ferraris, D. M., & Miggiano, R. (2023) · FEBS Letters · doi:10.1002/1873-3468.14680 · Cited by 8
Kadeřábková, N., Mahmood, A. J. S., Furniss, R. C. D., & Mavridou, D. A. I. (2023) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2023.05.003 · Cited by 9
Chen, Y., Li, T. L., Lin, X., Li, X., Li, X., & Guo, Z. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.790410 · Cited by 8
Unlocking Opportunities for Mycobacterium leprae and Mycobacterium ulcerans
Shyam, M., Kumar, S., & Singh, V. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00371 · Cited by 8
Berg, K. G., Hegde, P. V., Pujari, V., Brinkmann, M., Wilkins, D. Z., Parish, T., Crick, D. C., & Aldrich, C. C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115125 · Cited by 7
Self-citationEvans, C. E. B., Si, Y., Matarlo, J. S., Yin, Y., French, J. B., Tonge, P. J., & Tan, D. S. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00003 · Cited by 7
Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
Yelamanchi, S. D., Mishra, A., Behera, S. K., Karthikkeyan, G., Prasad, T. S. K., & Surolia, A. (2022) · Metabolites · doi:10.3390/metabo12060493 · Cited by 7
Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids
Daffé, M., Crick, D. C., & Jackson, M. (2015) · ASM Press eBooks · doi:10.1128/9781555818845.ch28 · Cited by 7
Self-citationAldrich, C. C., Boshoff, H. I., & Remmel, R. P. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc231 · Cited by 7
Mycobacterial MenG: Partial Purification, Characterization, and Inhibition
Pujari, V., Rožman, K., Dhiman, R. K., Aldrich, C. C., & Crick, D. C. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00190 · Cited by 6
Self-citationStructure-function insights into elusive Mycobacterium tuberculosis protein Rv1916
Antil, M., Sharma, J. N., Brissonnet, Y., Choudhary, M., Gouin, S. G., & Gupta, V. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.038 · Cited by 6
Kumar, S., Koehn, J. T., Juarrero, M. G., Crans, D. C., & Crick, D. C. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00312 · Cited by 6
Self-citationA stable analog of isochorismate for the study of MenD and other isochorismate-utilizing enzymes
Fang, M., Langman, B. M., & Palmer, D. R. J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.044 · Cited by 6
Song, H., Sung, H. P., Tse, Y. S., Jiang, M., & Guo, Z. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714019440 · Cited by 5
Synthesis, optimization, in vitro and in vivo study of bicyclic substituted amine as MenA inhibitor
Choi, S., & Narayanasamy, P. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128203 · Cited by 5
Self-citationAL-Hussein, W. K., & Jaragh-Alhadad, L. A. (2026) · Kuwait Journal of Science · doi:10.1016/j.kjs.2026.100557 · Cited by 4
Qin, M., Song, H., Dai, X., Chan, C., Chan, W., & Guo, Z. (2018) · ChemBioChem · doi:10.1002/cbic.201800143 · Cited by 4
Location of menaquinone and menaquinol headgroups in model membranes
Cleave, C. V., Murakami, H. A., Samart, N., Koehn, J. T., Maldonado, P., Kreckel, H. D., Cope, E. J., Basile, A., Crick, D. C., & Crans, D. C. (2020) · Canadian Journal of Chemistry · doi:10.1139/cjc-2020-0024 · Cited by 4
Self-citationHo, N. A. T., Given, F. M., Stanborough, T., Klein, M., Allison, T. M., Bulloch, E. M. M., Jiao, W., & Johnston, J. M. (2025) · ChemBioChem · doi:10.1002/cbic.202400943 · Cited by 3
Swaminath, S., Pradhan, A., Nair, R. R., & Ajitkumar, P. (2022) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2022.100142 · Cited by 3
Respiration and Oxidative Phosphorylation in Mycobacteria
Berney, M., & Cook, G. M. (2014) · Advances in photosynthesis and respiration · doi:10.1007/978-94-017-8742-0_15 · Cited by 3
Barman, A., Patra, M. M., & GUPTA, S. K. (2022) · Microbiology · doi:10.1099/mic.0.001192 · Cited by 3
Mycobacterial respiratory chain enzymes and growth are inhibited by decylubiquinone
Król, S. K., Kovaĺová, T., Janczak, M., Kalsum, S., Akber, M., Högbom, M., Brighenti, S., Ädelroth, P., & Brzezinski, P. (2025) · Communications Biology · doi:10.1038/s42003-025-09309-9 · Cited by 2
Self-control of vitamin K2 production captured in the crystal
Blaise, M., & Kremer, L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.h120.013113 · Cited by 2
Meehan, B. M., & Beckwith, J. R. (2017) · InTech eBooks · doi:10.5772/63342 · Cited by 3
Vitamin K2 Biosynthesis: Drug Targets for New Antibacterials
Kurosu, M. (2017) · InTech eBooks · doi:10.5772/65487 · Cited by 2
Self-citationWang, G., Dong, W., Bai, Y., Li, Y., Lu, H., Lu, W., Wang, C., Tang, J. Q., Li, P. Z., Wang, R., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09654-3 · Cited by 1
A Novel and Polymeric Inhibitor of MenA against Mycobacterium tuberculosisPreprint
Narayanasamy, P., & Crick, D. C. (2024) · Preprints.org · doi:10.20944/preprints202401.0325.v1 · Cited by 1
Self-citationPredicting the protein interaction landscape of a mycobacterial pathogenPreprint
Todor, H., Kim, L. M., Billings, E., Grzegorzewicz, A. E., Burkhart, H. N., DeJesus, M., Na, A., Nitz, S., Shell, S. S., Campbell, E. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.15.738315 · Cited by 1
Gabriel, H. B. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2011.tde-05082011-095206
The Membrane as a Novel Target Site for Antibiotics to Kill Persisting Bacterial Pathogens
Wu, X., & Hurdle, J. G. (2013) · Antibiotics · doi:10.1002/9783527659685.ch8
Strain dependent variations in iron metabolism of Mycobacterium avium subsp. paratuberculosis
Janagama, H. K. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)
Models, and Molecular Mechanisms Latent Tuberculosis Infection: Myths,
Dutta, N. K., & Karakousis, P. C. (2014)
Gabriel, H. B. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2016.tde-22022016-153037
The role of neutrophils in mycobacterial infection in zebrafish
Szkuta, P. T. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Segala, E. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique)
Tan, C., Wang, Y., dong, Q., Bai, Y., Li, Y., feng, J., Ren, X., Lu, H., Lu, W., Wang, C., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2295387/v1
Chaudhary, B., Sisodia, R., Sarmadhikari, D., Mazumdar, P. A., Asthana, S., & Madhurantakam, C. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2349545
Novel targets and drugs for the treatment of tuberculosis
Mazahir, F., Sirvi, P. K., Bhimrao, L. S., Mane, R., Kashyap, S., & Yadav, A. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24035-5.00010-4
Janagama, H. K., Lamont, E. A., George, S., Bannantine, J. P., Xu, W. W., Tu, Z. J., Wells, S. J., Schefers, J. M., & Sreevatsan, S. (2021) · Figshare · doi:10.6084/m9.figshare.14437073
Janagama, H. K., Lamont, E. A., George, S., Bannantine, J. P., Xu, W. W., Tu, Z. J., Wells, S. J., Schefers, J. M., & Sreevatsan, S. (2021) · Figshare · doi:10.6084/m9.figshare.14437067
Menaquinone depletion resensitises bedaquiline-resistant tuberculosisPreprint
Wetzel, J., Dallow, J., Davis, E., Pearson, W. H., Daems, S., Govaerts, M., Hereijgers, J., Sprangers, J., Truebody, B. E., Maes, V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.702511
Self-citationGunjan, Dhuriya, R. K., Kumari, G., Sharma, S., Ansari, M. M., & Singh, B. N. (2026) · Current Microbiology · doi:10.1007/s00284-026-05143-2
BindingDB Entry 50044288: Multitarget drug discovery for tuberculosis and other infectious diseases.
BindingDB (2015) · UC San Diego · doi:10.7270/q27p90zn
Metadata
- Authors
- Dhiman, R. K., Mahapatra, S., Slayden, R. A., Boyne, M. E., Lenaerts, A., Hinshaw, J. C., Angala, S. K., Chatterjee, D., Biswas, K., Narayanasamy, P., Kurosu, M., & Crick, D. C.
- Affiliations
- Colorado State University (US)
- University of Utah (US)
- Corresponding author
- Crick, Dean C.
- ORCID
- Venue
- Molecular Microbiology
- Publisher
- Wiley
- Published
- 2009-03-19
- Volume
- 72
- Issue
- 1
- Pages
- 85-97
- ISSN
- 0950-382X (ISSN-L)
- 1365-2958
- PMC
- PMC4747042
- OpenAlex
- W2152545013
- Cited by
- 146
- References
- 49
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 6 · 2021: 6 · 2020: 11 · 2019: 11 · 2018: 7 · 2017: 11 · 2016: 10 · 2015: 12 · 2014: 14 · 2013: 5 · 2012: 7
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R56AI049151, R01AI055298, AI049151, AI-06357, P01AI057836, R01AI049151, AI055298, AI057836)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- Mycobacterium tuberculosis, non-replicating persistence, latent tuberculosis infection, Middle East and North Africa, electron transport chain, oxygen consumption, bacterial persistence, tuberculosis drug development
- MeSH terms
- Adenosine Triphosphate, Mycobacterium tuberculosis, Oxygen Consumption, RNA, Bacterial, RNA, Messenger, Gene Expression Regulation, Bacterial, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Vitamin K 2, Electron Transport Chain Complex Proteins, Microbial Viability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review